Ebola Outbreak in Central Africa Declared Global Emergency

A significant Ebola outbreak, attributed to the rare Bundibugyo virus, is currently unfolding in Central Africa, primarily affecting the Democratic Republic of Congo (DRC) and Uganda. The World Health Organization (WHO) officially declared this outbreak a Public Health Emergency of International Concern (PHEIC) on May 17, 2026, underscoring the severity and potential for international spread. The outbreak originated in the Ituri Province of the Democratic Republic of Congo, with the earliest known cases emerging in late April 2026. Health authorities in the DRC officially confirmed the outbreak on May 15, 2026, after several weeks of undetected transmission. This marks the 17th recorded Ebola outbreak in the DRC since 1976, occurring just five months after the end of a previous outbreak. The situation rapidly escalated, prompting the WHO's declaration of a PHEIC, a classification indicating an extraordinary event posing a public health risk to other states and potentially requiring a coordinated international response. One of the most concerning aspects of this current outbreak is that it is caused by the Bundibugyo ebolavirus. Unlike the more common Zaire ebolavirus, for which an FDA-approved vaccine (Ervebo®) and specific treatments exist, there are currently no licensed vaccines or approved targeted antiviral treatments specifically for the Bundibugyo strain. This absence of specific medical countermeasures significantly complicates response efforts, forcing healthcare workers and aid organizations to rely on fundamental infection control measures and supportive care. While the Bundibugyo strain is historically associated with a somewhat lower case fatality rate (approximately 25-50%) compared to the Zaire strain (60-90%), it remains an extremely dangerous virus, with current mortality rates still around 30% or more. The geographical spread of the virus has been a major concern. The outbreak is concentrated in the Ituri Province, with confirmed cases also reported in North Kivu and South Kivu provinces in the DRC. Critically, the virus has crossed borders into neighboring Uganda, with confirmed cases reported in Kampala, the capital city, among individuals who traveled from the DRC. As of late May and early June 2026, reports indicate hundreds of suspected and confirmed cases and numerous deaths. For instance, as of May 29, 2026, 1,262 suspected and confirmed cases and at least 241 deaths had been reported across affected regions. Doctors Without Borders (MSF) reported 906 suspected cases, 125 confirmed cases, and 223 suspected deaths in DRC as of May 28, and 9 cases in Uganda as of May 29. Response efforts are being intensified by various international bodies. The WHO is actively scaling up support to the governments of DRC and Uganda, focusing on strengthening surveillance, contact tracing, clinical preparedness and management, delivery of supplies, and crucial community engagement. The Director-General of WHO made an urgent appeal for a ceasefire in the volatile eastern region of DRC to allow health workers safe access to affected populations. Doctors Without Borders has launched a large-scale response, deploying hundreds of medical, logistical, and support staff to the epicenter in Ituri. The ongoing insecurity, humanitarian crisis, and high population mobility in the affected regions of Central Africa further exacerbate the risk of rapid and widespread transmission. The urban or semi-urban nature of current hotspots and the large network of informal healthcare facilities also compound the challenges, echoing difficulties seen in past major Ebola epidemics. Additionally, there have been concerns regarding healthcare-associated transmission and gaps in infection prevention and control measures, with at least four deaths among healthcare workers reported. In response to the international spread, the U.S. Centers for Disease Control and Prevention (CDC) and the Department of Homeland Security (DHS) announced enhanced travel screening, entry restrictions, and public health measures to prevent Ebola from entering the United States. These measures include re-routing air travel for affected passengers from DRC, South Sudan, and Uganda to specific U.S. airports for enhanced screening and temporarily prohibiting certain non-U.S. citizens from entering if they have been in these countries within the past 21 days. An American exposed while caring for patients in DRC tested positive and was transported to Germany for treatment. Despite these measures, the overall risk to the American public is considered low. The global health community, including WHO's Technical Advisory Group, is actively discussing and prioritizing candidate vaccines and therapeutics for the Bundibugyo virus, with research and development efforts underway, although clinical trials for a Bundibugyo-specific vaccine would likely require at least seven months. The current outbreak highlights the persistent threat of emerging infectious diseases and the critical importance of sustained R&D investment for rare strains.

Frequently Asked Questions

Read Full Story on Quick Digest